Reply to: Comment on: “Adherence to hydroxyurea and clinical outcomes among children with sickle cell anemia”-Reference-Cited by-同舟云学术

Reply to: Comment on: “Adherence to hydroxyurea and clinical outcomes among children with sickle cell anemia”

Published:2023-08-17 Issue:11 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Reeves Sarah L.¹²^ORCID,Dombkowski Kevin J.¹,Peng Hannah K.¹,Phan Hanna³,Kolenic Giselle⁴,Creary Susan E.⁵^ORCID,Madden Brian¹,Lisabeth Lynda²

Affiliation:

1. Department of Pediatrics Susan B Meister Child Health Evaluation and Research (CHEAR) Center University of Michigan Ann Arbor Michigan USA

2. Department of Epidemiology School of Public Health University of Michigan Ann Arbor Michigan USA

3. College of Pharmacy University of Michigan Ann Arbor Michigan USA

4. Department of Biostatistics School of Public Health University of Michigan Ann Arbor Michigan USA

5. School of Medicine Nationwide Children's Hospital Center for Innovation in Pediatric Practice The Ohio State University Columbus Ohio USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30630

Reference5 articles.

1. Adherence to hydroxyurea and clinical outcomes among children with sickle cell anemia

2. Measuring hydroxyurea adherence by pharmacy and laboratory data compared with video observation in children with sickle cell disease

3. National Heart Lung and Blood Institute.The management of sickle cell disease.National Heart Lung and Blood Institute. Accessed February 22 2019.https://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pdf

4. National Quality Forum.Hydroxyurea use among children with sickle cell anemia.National Quality Forum. Accessed December 1 2021.http://www.qualityforum.org/QPS/3595

5. Identifying Sickle Cell Disease Cases Using Administrative Claims